Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Borealis Biosciences Appoints Christian Hordo as CEO and Expands Series A Financing
-
IBM Study: More Companies Turning to Open-Source AI Tools to Unlock ROI
-
Leading online retail brokerage tastytrade offers integration with TradingView
-
Impactive Capital Issues Letter to Basic-Fit CEO and Supervisory Board
-
Playa Bowls Chooses Qu to Support Rapid Growth and Streamline Operations Across Its Expanding Network of Locations
-
Innovate 32 Announces Partnership With Rachel Johnson & Associates
-
Sapience Therapeutics Receives FDA Orphan Drug Designation for ST316, a First-in-Class β-catenin Antagonist, for the Treatment of Familial Adenomatous Polyposis (FAP)
-
Pulse Biosciences, Inc. Announces Election to Exercise Company Warrants
-
Highwire Appoints Mike Steavenson as Executive Vice President of Enterprise Technology Practice, Elevates Jason Mayde to CTO
-
Inkhouse Taps Amanda Kelley as New York General Manager
-
NV5 Awarded $7 Million in Infrastructure Design Contracts by the City of Philadelphia
-
OHM FITNESS OPENS FIRST WEST VALLEY LOCATION
-
IPA to Present at The Microcap Conference 2025
-
Greene Park Capital Invests in Active Adult Community
-
FightCybercrime Offers Free Online Resource to Avoid Scams for Millions of Americans Receiving Gift Cards This Holiday Season
-
Quoin Pharmaceuticals Announces FDA Clearance to Initiate New QRX003 Netherton Syndrome Clinical Study
-
FIS Recognized for Outstanding Customer Satisfaction in IDC Treasury Awards
-
Trillium Surveyor and Kaiko Announce Strategic Partnership to Enhance Crypto Trade Surveillance
-
Visa Completes Acquisition of Featurespace
-
JumpCloud's G2 Scores Prove Its Leadership in Simplified IT Management
-
DeepCure Unveils STAT6 Inhibitor Program with Novel Oral Small Molecules Targeting Type 2 Inflammation
-
Pocamarket Wins 'Best K-POP Photocard Platform' at the 2024 KBS N Brand Awards
-
Anokion Announces the Early Completion of Enrollment in the ACeD-it Phase 2 and the SynCeD Phase 2a Trials of KAN-101 for the Treatment of Celiac Disease
-
GTT Announces Access to Oracle Cloud Infrastructure via FastConnect
-
OutSystems Named a Leader in G2’s Inaugural 2025 Grid® Report for Low-Code Development Platforms
-
USound Unveils Ultrasonic Micro Module for Distance Measurement and Proximity Sensing Applications at CES
-
Maxar Awarded $35M in New Tasking Contracts by Two Government Customers in Asia-Pacific Region
-
Driivz Concludes 2024 with Significant Growth for its EV Charging & Energy Management Platform
-
An On-Site Medical Unit Saved a Nissan Employee’s Life – Now, She’s Part of the Team
-
AgEagle Aerial Systems Announces Milestone Order of 60 RedEdge-P Multispectral Sensors
-
Pluri Congratulates Mesoblast on FDA Approval of First Mesenchymal Stromal Cell Therapy for Steroid-Refractory Acute Graft-Versus-Host Disease
-
Liberty Star Announces Assay Results from The Hay Mountain Project Red Rock Canyon MEP Area Containing Bonanza Grade Gold Results
-
Ladybug Resource Group Accelerates Strategy and Expands E-Commerce Portfolio With Key Acquisitions
-
Duos Partners with Texas City for Data Center Development
-
Ultragenyx Submits Biologics License Application to the U.S. FDA for UX111 AAV Gene Therapy for the Treatment of Sanfilippo Syndrome Type A (MPS IIIA)
-
Sky Quarry Inc. Issues Annual Shareholder Letter and Corporate Update
-
Gold and Gemstone Mining Achieves Record $8.6 Million Revenue
-
Gaxos.ai Inc. Announces $5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
-
Union Pacific Corporation Announces Fourth Quarter 2024 Earnings Release Date
-
Aquestive Therapeutics Receives U.S. FDA Orphan Drug Exclusivity for Libervant® (diazepam) Buccal Film in Pediatric Patients with Seizure Clusters Ages Two to Five
-
Standard BioTools to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
Assembly Biosciences Announces $30.1 Million Equity Investment and Accelerated Funding from Gilead to Advance Clinical Development Programs
-
Bionano Announces the Publication of Stockholder Letter Regarding Support for Proxy Proposal
-
Golden Matrix Group to Participate in the 2025 ICR Conference
-
Shareholder Update From the Desk of H. Wyatt Flippen, CEO and Board Member
-
authID Bolsters Security and Transparency for Philanthropy Efforts with Program Expansion at EinStrong Foundation
-
D. Boral Capital Acted as Exclusive Placement Agent to Webuy Global Ltd (Nasdaq: WBUY) in connection with its $3.7 Million Registered Direct Offering
-
Immuneering Launches Pancreatic Cancer Advisory Board
-
Applied Digital Sets Fiscal Second Quarter 2025 Conference Call for Tuesday, January 14, 2025, at 5:00 p.m. Eastern Time
-
illumin Announces TSX Acceptance of Normal Course Issuer Bid
